A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 249
Summary
- Conditions
- Biliary Tract Cancer (BTC)
- Colorectal Cancer (CRC)
- Endometrial Cancer
- Gastroesophageal Cancer (GC)
- Ovarian Cancer
- Solid Tumors
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: Non-RandomizedIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03314935
- Collaborators
- Not Provided
- Investigators
- Study Director: Sven Gogov, MD Incyte Corporation
Get Well Soon